PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

National Academy of Inventors partners with PMU to recognize three exceptional innovators

2024-12-12
(Press-News.org) The National Academy of Inventors (NAI) is proud to announce the recipients of the inaugural Prince Mohammad bin Fahd University (PMU)-National Academy of Inventors International Patent Award. This year’s recipients will be honored at a special ceremony on December 12th, 2024 at PMU’s campus in Al-Khobar, Kingdom of Saudi Arabia.

The PMU-NAI International Patent Award was created to recognize and honor distinguished scientists, research institutions, research centers, and universities across the globe for their outstanding patents and inventions that create positive societal impact. This year, the award nomination process had overwhelming participation with 61 applicants representing over 30 institutions around the world. From this pool of applicants, a prize recipient was chosen in each of the 3 prize categories: 1st place, to be awarded $25,000; 2nd place, to be awarded $15,000; and 3rd place, to be awarded $10,000. The Award prize will assist in funding the commercialization of the innovator’s patented technology.

"As the role of Prince Mohammad bin Fahd University extends beyond the campus, focusing on fostering innovation and sharing knowledge on a broader scale. We are happy to be an NAI Sustaining Member Institution, committed to recognizing and celebrating inventors not only for their impactful contributions but also for their dedication to translating and scaling up their innovations into transformative technologies that make a meaningful difference,” said Dr. Faisal Yousif, Vice President for Academic Affairs at PMU. 

“We are proud to partner with the Academy in their mission to recognize and support inventors who are driving positive change through their work. This shared commitment to innovation and the protection of intellectual property enables us to celebrate those who are not only advancing groundbreaking ideas but also ensuring that their inventions can make a meaningful impact. Today, we are pleased to honor three outstanding scientists whose dedication to safeguarding their intellectual property has allowed their innovations to flourish and benefit society."

 This year’s recipients include:

1st Place: Tara Alvarez, Distinguished Professor, New Jersey Institute of Technology. Awarded for her patent “Method, system, and apparatus for treatment of binocular dysfunctions”. This innovation allows for a higher standard of care for patients with binocular dysfunction by utilizing virtual reality to record and analyze eye movements for improved therapies, while minimizing negative side effects, such as headache, fatigue, and blurred vision. 2nd Place: Shane Farritor, David B. and Nancy K. Lederer Professor of Engineering, University of Nebraska-Lincoln. Awarded for his patent “Robotically Assisted Surgical System and Related Devices and Methods”. His MIRA (“miniaturized in vivo robotic assistant”) Surgical System is the first articulating miniature robot designed to be physically inserted into the body to perform surgery, enabling minimally invasive robotic surgery and reduced hospital stays and complications for patients. Its compact size and lower cost of operation allows it to be deployed in rural medical facilities, military battlefields, developing countries, and even in space. 3rd Place: Susan Trammell, Professor of Physics and Optical Science, The University of North Carolina at Charlotte. Awarded for her patent “Methods and compositions for biopreservation”. Her preservation method through an amorphous matrix helps in creating precise drying and temperature control, which is essential for preserving sensitive biological samples. This preservation method can be applied in the medical and pharmaceutical fields, in biotechnologies and research settings, and across the agriculture industry. “This award highlights the importance of intellectual property protection and value of the U.S. patent not just within the U.S., but across the globe. More and more international inventors are pursuing U.S. patents, highlighting its strength in the global marketplace and the crucial role it plays in translating and advancing fundamental technologies,” said Dr. Sanberg, FNAI, President of the NAI.  “PMU’s mission of transformative impact and their commitment to the global innovation community makes them the perfect partner for an award recognizing innovators at an international level. It is an honor to partner with them to recognize these incredible individuals who have developed meaningful innovations and are actively translating them to the world marketplace for the benefit of society.” 

To be considered for the award, inventors must have received a patent from the United States Patent Office (USPTO) for their innovative idea in the past 5 years and once their technology is translated and/or scaled up, must plausibly create a positive impact for society. They must also be affiliated with an NAI Member Institution. Learn more about the PMU-NAI International Patent Award.

About the National Academy of Inventors

The National Academy of Inventors (NAI) is a member organization comprising U.S. and international universities, and governmental and non-profit research institutes, with over 4,000 individual inventor members and Fellows spanning more than 250 institutions. It was founded in 2010 to recognize and encourage inventors with patents issued from the U.S. Patent and Trademark Office, enhance the visibility of academic technology and innovation, encourage the disclosure of intellectual property, educate and mentor innovative students, and translate the inventions of its members to benefit society. The Academy and the USPTO have enjoyed a collaborative partnership since the founding of NAI. Most recently this has been reflected in their joint mission to expand access to underrepresented individuals and institutions participating in the invention and innovation ecosystem. www.academyofinventors.org

END


ELSE PRESS RELEASES FROM THIS DATE:

Deep learning model accurately diagnoses COPD

Deep learning model accurately diagnoses COPD
2024-12-12
OAK BROOK, Ill. – Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA). COPD is a group of progressive lung diseases that impair a person’s ability to breathe. Symptoms typically involve shortness of breath and fatigue. There currently is no cure for COPD, and it is the third leading cause of death worldwide, according to the World Health Organization. A ...

Alliance Foundation Trials phase III PATINA study shows promise for patients with HR+, HER2+ metastatic breast cancer

2024-12-12
Alliance Foundation Trials, LLC (AFT) and Pfizer Inc. today announced results from the phase III PATINA trial demonstrating that the addition of palbociclib (IBRANCE®) to current standard-of-care first-line maintenance therapy (following induction chemotherapy) resulted in statistically significant and clinically meaningful improvement in progression-free survival (PFS) by investigator assessment in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+) metastatic ...

COMET trial finds quality of life similar among patients with low- risk DCIS whether they received active monitoring or surgery

2024-12-12
SAN ANTONIO – Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, according to results from the COMET clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024. The results of this study were simultaneously published in JAMA Oncology. “Active monitoring” is a strategy in which patients are monitored closely, with surgery reserved for those patients who ...

Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation

2024-12-12
SAN ANTONIO – For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the same breast, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024. “Good-risk” DCIS was defined as grade 1 or 2, 2.5 cm or smaller, and having clear surgical margins of 3 mm or greater. Current guidelines from the National Comprehensive Cancer Network (NCCN) advise that patients who undergo breast-conserving surgery after a diagnosis ...

COMET trial finds active monitoring is a viable option for some patients with low-risk DCIS

2024-12-12
SAN ANTONIO – Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ipsilateral breast cancer recurrence rates as those who underwent guideline-concordant treatment, according to results from the COMET clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024. The results of this study were simultaneously published in JAMA. “Active monitoring” is a strategy in which patients are monitored closely, with surgery reserved for those patients who develop cancer. A steady increase ...

Most patients with intermediate-risk breast cancer may safely avoid chest wall irradiation after mastectomy

2024-12-12
SAN ANTONIO – Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent chest wall irradiation (CWI) after mastectomy, according to results from the BIG 2-04 MRC SUPREMO clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024. “While post-mastectomy CWI is the standard of care for most patients with early-stage breast cancer who have four or more positive axillary lymph nodes, its role in patients with fewer positive lymph nodes or node-negative disease remains controversial,” ...

Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ

2024-12-12
About The Study: Women with low-risk ductal carcinoma in situ randomized to active monitoring did not have a higher rate of invasive cancer in the same breast at 2 years compared with those randomized to guideline-concordant care.  Corresponding Author: To contact the corresponding author, E. Shelley Hwang, MD, MPH, email shelley.hwang@duke.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2024.26698) Editor’s Note: Please ...

Patient-reported outcomes for low-risk ductal carcinoma in situ

2024-12-12
About The Study: In this prespecified secondary analysis of the Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) prospective randomized trial, the overall lived experience of women randomized to undergo active monitoring for low-risk ductal carcinoma in situ was similar to that of women randomized to guideline-concordant care during the 2 years following diagnosis.  Corresponding Author: To contact the corresponding author, Ann H. Partridge, MD, MPH, email ann_partridge@dfci.harvard.edu. To access the embargoed study: Visit our For The Media website ...

Women born prematurely are at greater risk of committing suicide

Women born prematurely are at greater risk of committing suicide
2024-12-12
Not only are they the smallest among us, premature children also face health and life challenges that make them the most vulnerable. Generally speaking, they have a slightly higher risk of mortality due to illness. It is now apparent that they also have a higher risk of unexpected death from so-called external causes: road traffic accidents, substance abuse and suicide. This has been revealed in a major Nordic study led by Professor Kari Risnes from the Faculty of Medicine and Health Sciences at the Norwegian University of Science and Technology (NTNU). The researchers have analyzed birth data and causes of death for nearly 37,000 individuals aged between 15 ...

Bovhyaluronidaze azoximer significantly reduces exercise intolerance in patients with long-term pulmonary sequelae of COVID-19

2024-12-12
Petrovax announced today the positive results from “Long-CoV-III-21,” a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of bovhyaluronidase azoximer in adult patients with pulmonary sequelae of COVID-19. Bovhyaluronidase azoximer, marketed under the brand name Longidaza, is a polymer-conjugated hyaluronidase with an extended half-life. The study drug and placebo were administered for 71 days, with an observation period extending to Day 180. Longidaza demonstrated a statistically significant 62% reduction in the proportion of patients with exertional desaturation ...

LAST 30 PRESS RELEASES:

New grant to UMD School of Public Health will uncover “ghost networks” in Medicare plans

Researchers describe a potential target to address a severe heart disease in diabetic patients

U-M study of COVID-19 deaths challenges claims, understanding of pandemic-era suicides

How the dirt under our feet could affect human health

Screen time is a poor predictor of suicide risk, Rutgers researchers find

Dual-unloading mode revolutionizes rice harvesting and transportation

Researchers uncover strong light-matter interactions in quantum spin liquids

More dense, populated neighborhoods inspire people to walk more

Innovative biomimetic superhydrophobic coating combines repair and buffering properties for superior anti-erosion

New analytical approach revolutionizes reliability evaluation of power systems with renewable energy

Artificial intelligence improves mammography-based risk prediction

Brain tumors hijack circadian clock to grow

Pfizer-BioNTech vaccine for COVID-19 among children ages 5-17

Trends in school mental health and substance use education

Genes that determine tooth shape identified

With a little help from their friends: Poll shows role of close friendships in older adults’ health

Too much screen time can reduce sleep quality in preschool-age children, making behavioral problems worse

Study reveals role of allele dosage in improving sweetpotato traits

Dan M. Frangopol and Sunyong Kim co-author third book on structural performance

Ferroptosis and intrinsic drug-induced liver injury by acetaminophen and other drugs: a critical evaluation and historical perspective

Reiki therapy demonstrates significant symptom relief for cancer patients receiving infusion treatments

Long-term exposure to air pollution linked to blood clots in veins that bring blood to the heart

National Academy of Inventors partners with PMU to recognize three exceptional innovators

Deep learning model accurately diagnoses COPD

Alliance Foundation Trials phase III PATINA study shows promise for patients with HR+, HER2+ metastatic breast cancer

COMET trial finds quality of life similar among patients with low- risk DCIS whether they received active monitoring or surgery

Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation

COMET trial finds active monitoring is a viable option for some patients with low-risk DCIS

Most patients with intermediate-risk breast cancer may safely avoid chest wall irradiation after mastectomy

Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ

[Press-News.org] National Academy of Inventors partners with PMU to recognize three exceptional innovators